230 related articles for article (PubMed ID: 27973588)
21. Role of the CD137 ligand (CD137L) signaling pathway during Mycobacterium tuberculosis infection.
Martínez Gómez JM; Koh VH; Yan B; Lin W; Ang ML; Rahim SZ; Pethe K; Schwarz H; Alonso S
Immunobiology; 2014 Jan; 219(1):78-86. PubMed ID: 24091276
[TBL] [Abstract][Full Text] [Related]
22. Suboptimal Antigen Presentation Contributes to Virulence of Mycobacterium tuberculosis In Vivo.
Grace PS; Ernst JD
J Immunol; 2016 Jan; 196(1):357-64. PubMed ID: 26573837
[TBL] [Abstract][Full Text] [Related]
23. Rapid rebound of the Treg compartment in DEREG mice limits the impact of Treg depletion on mycobacterial burden, but prevents autoimmunity.
Berod L; Stüve P; Varela F; Behrends J; Swallow M; Kruse F; Krull F; Ghorbani P; Mayer CT; Hölscher C; Sparwasser T
PLoS One; 2014; 9(7):e102804. PubMed ID: 25050936
[TBL] [Abstract][Full Text] [Related]
24. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV].
Nikonenko BV; Mezhlumova MB; Moroz AM
Biull Eksp Biol Med; 1990 Nov; 110(11):526-8. PubMed ID: 2128037
[TBL] [Abstract][Full Text] [Related]
25. Dominant-negative tumor necrosis factor protects from Mycobacterium bovis Bacillus Calmette Guérin (BCG) and endotoxin-induced liver injury without compromising host immunity to BCG and Mycobacterium tuberculosis.
Olleros ML; Vesin D; Lambou AF; Janssens JP; Ryffel B; Rose S; Frémond C; Quesniaux VF; Szymkowski DE; Garcia I
J Infect Dis; 2009 Apr; 199(7):1053-63. PubMed ID: 19222369
[TBL] [Abstract][Full Text] [Related]
26. Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host.
Torrelles JB; Schlesinger LS
Tuberculosis (Edinb); 2010 Mar; 90(2):84-93. PubMed ID: 20199890
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive insights into transcriptional adaptation of intracellular mycobacteria by microbe-enriched dual RNA sequencing.
Rienksma RA; Suarez-Diez M; Mollenkopf HJ; Dolganov GM; Dorhoi A; Schoolnik GK; Martins Dos Santos VA; Kaufmann SH; Schaap PJ; Gengenbacher M
BMC Genomics; 2015 Feb; 16(1):34. PubMed ID: 25649146
[TBL] [Abstract][Full Text] [Related]
28. The Diversity Outbred Mouse Population Is an Improved Animal Model of Vaccination against Tuberculosis That Reflects Heterogeneity of Protection.
Kurtz SL; Rossi AP; Beamer GL; Gatti DM; Kramnik I; Elkins KL
mSphere; 2020 Apr; 5(2):. PubMed ID: 32295871
[TBL] [Abstract][Full Text] [Related]
29. Modeling Diversity: Do Homogeneous Laboratory Strains Limit Discovery?
Smith CM; Sassetti CM
Trends Microbiol; 2018 Nov; 26(11):892-895. PubMed ID: 30166218
[TBL] [Abstract][Full Text] [Related]
30. Influence of phthiocerol dimycocerosate on CD4(+) T cell priming and persistence during Mycobacterium tuberculosis infection.
Pinto R; Nambiar JK; Leotta L; Counoupas C; Britton WJ; Triccas JA
Tuberculosis (Edinb); 2016 Jul; 99():25-30. PubMed ID: 27450001
[TBL] [Abstract][Full Text] [Related]
31. The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy.
Trauner A; Liu Q; Via LE; Liu X; Ruan X; Liang L; Shi H; Chen Y; Wang Z; Liang R; Zhang W; Wei W; Gao J; Sun G; Brites D; England K; Zhang G; Gagneux S; Barry CE; Gao Q
Genome Biol; 2017 Apr; 18(1):71. PubMed ID: 28424085
[TBL] [Abstract][Full Text] [Related]
32. CD4+ T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo.
Cowley SC; Elkins KL
J Immunol; 2003 Nov; 171(9):4689-99. PubMed ID: 14568944
[TBL] [Abstract][Full Text] [Related]
33. Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis.
Borrell S; Gagneux S
Clin Microbiol Infect; 2011 Jun; 17(6):815-20. PubMed ID: 21682802
[TBL] [Abstract][Full Text] [Related]
34. Immunological consequences of strain variation within the Mycobacterium tuberculosis complex.
Tientcheu LD; Koch A; Ndengane M; Andoseh G; Kampmann B; Wilkinson RJ
Eur J Immunol; 2017 Mar; 47(3):432-445. PubMed ID: 28150302
[TBL] [Abstract][Full Text] [Related]
35. Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection.
Muflihah H; Flórido M; Lin LCW; Xia Y; Triccas JA; Stambas J; Britton WJ
PLoS One; 2021; 16(11):e0259829. PubMed ID: 34793507
[TBL] [Abstract][Full Text] [Related]
36. Genetic diversity and dynamic distribution of Mycobacterium tuberculosis isolates causing pulmonary and extrapulmonary tuberculosis in Thailand.
Srilohasin P; Chaiprasert A; Tokunaga K; Nishida N; Prammananan T; Smittipat N; Mahasirimongkol S; Chaiyasirinroje B; Yanai H; Palittapongarnpim P
J Clin Microbiol; 2014 Dec; 52(12):4267-74. PubMed ID: 25297330
[TBL] [Abstract][Full Text] [Related]
37. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
38. Mathematical Models for the Epidemiology and Evolution of Mycobacterium tuberculosis.
Pečerska J; Wood J; Tanaka MM; Stadler T
Adv Exp Med Biol; 2017; 1019():281-307. PubMed ID: 29116641
[TBL] [Abstract][Full Text] [Related]
39. Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon.
Wozniak TM; Saunders BM; Ryan AA; Britton WJ
Infect Immun; 2010 Oct; 78(10):4187-94. PubMed ID: 20679438
[TBL] [Abstract][Full Text] [Related]
40. Evolution of
Nimmo C; Millard J; Faulkner V; Monteserin J; Pugh H; Johnson EO
Front Cell Infect Microbiol; 2022; 12():954074. PubMed ID: 36275027
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
